Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Medtronic (MDT)

Medtronic corrects guaranteed delivery deadline in MiniMed exchange offer prospectus

Neutral Impact 2 of 5 shareholder Written later

Medtronic filed an 8-K on September 17, 2026 to correct a typographical error in the prospectus for its exchange offer of MiniMed Group common stock for Medtronic ordinary shares. The prospectus had stated that a notice of guaranteed delivery would expire at 12:00 midnight, New York City time, while the corrected deadline is 5:00 p.m. New York City time on the second NYSE trading day after the notice is executed. Shareholders who plan to use guaranteed delivery need to meet the corrected deadline.

Key points

  • Medtronic commenced the exchange offer on September 14, 2026, for up to 225,361,295 newly issued MiniMed common shares.
  • The guaranteed delivery deadline is corrected to 5:00 p.m. New York City time on the second NYSE trading day after execution of the notice.
  • If the offer is oversubscribed, Medtronic currently intends to accept additional shares not exceeding two percent of total outstanding Medtronic ordinary shares.
  • Shareholders should read the Prospectus; D.F. King & Co., Inc. is the information agent at (877) 361-7972.

The filing

CompanyMedtronic (MDT)
Form8-K, current report
Filed with the SECSep 17, 2026, 4:19 PM ET
Accession number0001628280-26-062505

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.